swii.ch is a strategic consultancy that helps biopharma teams solve the hardest problems in rare disease — from early patient identification to EU JCA readiness. We combine behavioural science, digital innovation, and regulatory fluency to deliver insight-led solutions that accelerate access, build trust, and empower patients
